Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A injection frequency in children with cerebral palsy
ACTRN12607000326493Phase 3Completed
- Sponsor
- The Royal Children's Hospital
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in cerebral palsy (CP) (2 arms), sponsored by The Royal Children's Hospital. Primary endpoint: Passive length of gastrocnemius in degrees of dorsiflexion. Started Jul 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ACTRN12607000326493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000326493.